Stock data
NovoCure Limited (NVCR)
NovoCure Limited (NVCR) reported revenue of US$655.35M and net income of -US$136.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$655.35M | US$488.47M | -US$153.80M | -US$136.23M | — |
| 2024 | US$605.22M | US$468.04M | -US$170.50M | -US$168.63M | — |
| 2023 | US$509.34M | US$381.06M | -US$232.87M | -US$207.04M | — |
| 2022 | US$537.84M | US$422.97M | -US$89.52M | -US$92.53M | — |
| 2021 | US$535.03M | US$420.15M | -US$44.33M | -US$58.35M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$183.58M | -US$15.66M | — |
| 2026-03-31 | US$174.06M | -US$71.14M | — |
| 2025-12-31 | US$174.35M | -US$24.50M | — |
| 2025-09-30 | US$167.20M | -US$37.27M | — |
| 2025-06-30 | US$158.81M | -US$40.14M | — |
| 2025-03-31 | US$154.99M | -US$34.32M | — |
| 2024-12-31 | US$161.27M | -US$65.92M | — |
| 2024-09-30 | US$155.09M | -US$30.57M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.